Chloral Hydrate Preconditioning Protects Against Ischemic Stroke via Upregulating Annexin A1

CNS Neuroscience and Therapeutics

Volumn 21, Issue 9, 2015, Pages 718-726

  Liu, Jiu Hong ^a   Feng, Dan ^a   Zhang, Yu Fen ^a   Shang, You ^a   Wu, Yan ^a   Li, Xiao Feng ^b   Pei, Lei ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b PEOPLE'S HOSPITAL OF GUANGXI ZHUANG AUTONOMOUS REGION   (China)

Author keywords

Annexin A1; Inflammation; Preconditioning; Stroke

Indexed keywords

CHLORAL HYDRATE; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 4; INTERLEUKIN 6; LIPOCORTIN 1; MESSENGER RNA; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; ANNEXIN A1, MOUSE; CYTOKINE; NEUROPROTECTIVE AGENT; OLIGOPEPTIDE; T-BUTYLOXYCARBONYL-METHIONYL-LEUCYL-PHENYLALANINE;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BRAIN EDEMA; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; CONTROLLED STUDY; FUNCTIONAL STATUS; GENE EXPRESSION; ISCHEMIC PRECONDITIONING; MALE; MICROGLIA; MIDDLE CEREBRAL ARTERY OCCLUSION; MOUSE; NEUROPROTECTION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; SURVIVAL RATE; ANIMAL; ANTAGONISTS AND INHIBITORS; BRAIN; C57BL MOUSE; CEREBRAL ARTERY DISEASE; CONVALESCENCE; DISEASE MODEL; DRUG EFFECTS; GENETICS; KNOCKOUT MOUSE; METABOLISM; MOTOR ACTIVITY; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; RANDOMIZATION; STROKE;

ANIMALS; ANNEXIN A1; BRAIN; BRAIN EDEMA; BRAIN ISCHEMIA; CHLORAL HYDRATE; CYTOKINES; DISEASE MODELS, ANIMAL; INFARCTION, MIDDLE CEREBRAL ARTERY; MALE; MICE, INBRED C57BL; MICE, KNOCKOUT; MOTOR ACTIVITY; NEUROPROTECTIVE AGENTS; OLIGOPEPTIDES; RANDOM ALLOCATION; RECOVERY OF FUNCTION; STROKE;

EID: 84939258450     PISSN: 17555930     EISSN: 17555949     Source Type: Journal    
DOI: 10.1111/cns.12435     Document Type: Article

References (39)

1. Iadecola C, Anrather J. Stroke research at a crossroad: asking the brain for directions. Nat Neurosci 2011;14:1363-1368.
2. Dirnagl U, Becker K, Meisel A. Preconditioning and tolerance against cerebral ischemia: from experimental strategies to clinical use. Lancet Neurol 2009;8:398-412.
3. Wells BA, Keats AS, Cooley DA. Increased tolerance to cerebral ischemia produced by general anesthesia during temporary carotid occlusion. Surgery 1963;54:216-223.
4. Baxter MG, Murphy KL, Taylor PM, Wolfensohn SE. Chloral hydrate is not acceptable for anesthesia or euthanasia of small animals. Anesthesiology 2009;111:209; author reply 209-10.
5. Goldstein A Jr, Wells BA, Keats AS. Increased tolerance to cerebral anoxia by pentobarbital. Arch Int Pharmacodyn Ther 1966;161:138-143.
6. Mellon RD, Simone AF, Rappaport BA. Use of anesthetic agents in neonates and young children. Anesth Analg 2007;104:509-520.
7. Sury MR, Fairweather K. The effect of melatonin on sedation of children undergoing magnetic resonance imaging. Br J Anaesth 2006;97:220-225.
8. Uematsu M, Takasawa M, Hosoi R, Inoue O. Uncoupling of flow and metabolism by chloral hydrate: a rat in-vivo autoradiographic study. NeuroReport 2009;20:219-222.
9. Pan Q, Liu Y, Zheng J, et al. Protective effect of chloral hydrate against lipopolysaccharide/D-galactosamine-induced acute lethal liver injury and zymosan-induced peritonitis in mice. Int Immunopharmacol 2010;10:967-977.
10. Flower RJ. Eleventh Gaddum memorial lecture. Lipocortin and the mechanism of action of the glucocorticoids. Br J Pharmacol 1988;94:987-1015.
11. Buckingham JC, John CD, Solito E, et al. Annexin 1, glucocorticoids, and the neuroendocrine-immune interface. Ann N Y Acad Sci 2006;1088:396-409.
12. Gavins FN, Dalli J, Flower RJ, Granger DN, Perretti M. Activation of the annexin 1 counter-regulatory circuit affords protection in the mouse brain microcirculation. FASEB J 2007;21:1751-1758.
13. Hannon R, Croxtall JD, Getting SJ, et al. Aberrant inflammation and resistance to glucocorticoids in annexin 1-/- mouse. FASEB J 2003;17:253-255.
14. Willems E, Leyns L, Vandesompele J. Standardization of real-time PCR gene expression data from independent biological replicates. Anal Biochem 2008;379:127-129.
15. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951;193:265-275.
16. Koch S, Sacco RL, Perez-Pinzon MA. Preconditioning the brain: moving on to the next frontier of neurotherapeutics. Stroke 2012;43:1455-1457.
17. Crisostomo PR, Wairiuko GM, Wang M, Tsai BM, Morrell ED, Meldrum DR. Preconditioning versus postconditioning: mechanisms and therapeutic potentials. J Am Coll Surg 2006;202:797-812.
18. Silverman J, Muir WW 3rd. A review of laboratory animal anesthesia with chloral hydrate and chloralose. Lab Anim Sci 1993;43:210-216.
19. Gauillard J, Cheref S, Vacherontrystram MN, Martin JC. Chloral hydrate: a hypnotic best forgotten? Encephale 2002;28:200-204.
20. Maud P, Thavarak O, Cedrick L, et al. Evidence for the use of isoflurane as a replacement for chloral hydrate anesthesia in experimental stroke: an ethical issue. Biomed Res Int 2014;2014:802539.
21. Warner DS, McFarlane C, Todd MM, Ludwig P, McAllister AM. Sevoflurane and halothane reduce focal ischemic brain damage in the rat. Possible influence on thermoregulation. Anesthesiology 1993;79:985-992.
22. Werner C, Mollenberg O, Kochs E, Schulte J. Sevoflurane improves neurological outcome after incomplete cerebral ischemia in rats. Br J Anaesth 1995;75:756-760.
23. Engelhard K, Werner C, Reeker W, et al. Desflurane and isoflurane improve neurological outcome after incomplete cerebral ischemia in rats. Br J Anaesth 1999;83:415-421.
24. Pera J, Zawadzka M, Kaminska B, Szczudlik A. Influence of chemical and ischemic preconditioning on cytokine expression after focal brain ischemia. J Neurosci Res 2004;78:132-140.
25. Clarkson AN, Rahman R, Appleton I. Inflammation and autoimmunity as a central theme in neurodegenerative disorders: fact or fiction? Curr Opin Investig Drugs 2004;5:706-713.
26. Fassbender K, Rossol S, Kammer T, et al. Proinflammatory cytokines in serum of patients with acute cerebral ischemia: kinetics of secretion and relation to the extent of brain damage and outcome of disease. J Neurol Sci 1994;122:135-139.
27. Tarkowski E, Rosengren L, Blomstrand C, et al. Early intrathecal production of interleukin-6 predicts the size of brain lesion in stroke. Stroke 1995;26:1393-1398.
28. Vila N, Castillo J, Davalos A, Chamorro A. Proinflammatory cytokines and early neurological worsening in ischemic stroke. Stroke 2000;31:2325-2329.
29. Takao Y, Mikawa K, Nishina K, Maekawa N, Obara H. Lidocaine attenuates hyperoxic lung injury in rabbits. Acta Anaesthesiol Scand 1996;40:318-325.
30. Levin SG, Godukhin OV. Anti-inflammatory cytokines, TGF-beta1 and IL-10, exert anti-hypoxic action and abolish posthypoxic hyperexcitability in hippocampal slice neurons: comparative aspects. Exp Neurol 2011;232:329-332.
31. Boche D, Cunningham C, Gauldie J, Perry VH. Transforming growth factor-beta 1-mediated neuroprotection against excitotoxic injury in vivo. J Cereb Blood Flow Metab 2003;23:1174-1182.
32. Li L, Wu Y, Wang Y, et al. Resolvin D1 promotes the interleukin-4-induced alternative activation in BV-2 microglial cells. J Neuroinflammation 2014;11:72.
33. Xiong X, Barreto GE, Xu L, Ouyang YB, Xie X, Giffard RG. Increased brain injury and worsened neurological outcome in interleukin-4 knockout mice after transient focal cerebral ischemia. Stroke 2011;42:2026-2032.
34. Pei L, Zhang J, Zhao F, et al. Annexin 1 exerts anti-nociceptive effects after peripheral inflammatory pain through formyl-peptide-receptor-like 1 in rat dorsal root ganglion. Br J Anaesth 2011;107:948-958.
35. Perretti M. The annexin 1 receptor(s): is the plot unravelling? Trends Pharmacol Sci 2003;24:574-579.
36. Gavins FN, Kamal AM, D'Amico M, Oliani SM, Perretti M. Formyl-peptide receptor is not involved in the protection afforded by annexin 1 in murine acute myocardial infarct. FASEB J 2005;19:100-102.
37. Relton JK, Strijbos PJ, O'Shaughnessy CT, et al. Lipocortin-1 is an endogenous inhibitor of ischemic damage in the rat brain. J Exp Med 1991;174:305-310.
38. Rothwell N, Allan S, Toulmond S. The role of interleukin 1 in acute neurodegeneration and stroke: pathophysiological and therapeutic implications. J Clin Invest 1997;100:2648-2652.
39. Luo Z, Gao Y, Sun N, et al. Enhancing the interaction between annexin-1 and formyl peptide receptors regulates microglial activation to protect neurons from ischemia-like injury. J Neuroimmunol 2014;276:24-36.